[ Vineti raises $13.75M in Series A ]
Vineti has raised $13.75 million in Series A funding.
Founded in 2016, Vineti is an intelligent analytics platform that provides personalised cell and gene therapeutics development and delivery solutions.
The new financing will be used to grow its team and to deliver the first cloud-based software solution to improve patient access, accelerate life-saving treatment delivery, and promote safety and regulatory compliance for individualized cell therapies.
|City||San Francisco, California|
|Founder / CEO||Amy DuRoss|
|Mayo Clinic Ventures|